secwatch.observer — SEC 8-K summary
======================================

Issuer:     REGENERON PHARMACEUTICALS, INC. (REGN)
CIK:        0000872589
Form:       8-K
Filed at:   2026-01-12T23:59:59+00:00
Accession:  0001104659-26-002691
Event type: other_material
Sentiment:  neutral
Materiality: 0.20
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Regeneron expects Q4 IPR&D charge of ~$19M and $60M matching donation charge
----------------------------------------------------------------------------

- Expects ~$19M pre-tax IPR&D charge in Q4 2025, reducing GAAP and non-GAAP diluted EPS by ~$0.14.
- Records ~$60M SG&A charge for matching donations to Good Days retinal fund in Q4 2025.
- Preliminary Q4 and FY2025 financial update provided at J.P. Morgan Healthcare Conference.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/872589/000110465926002691/0001104659-26-002691-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/872589/000110465926002691/tm262861d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-002691

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer